Cargando…

FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids

Disclosure: M. Rodriguez Caballero: None. F. Romero: None. C. Escurra: None. R. Rodriguez: None. R. Rolon: None. E. Valinotti: None. A. Ayala: None. Granulomatous hypophysitis corresponds to 1% of sellar lesions. It maybe primary or secondary to tuberculosis, Pneumocystis carinii, Toxoplasma gondii,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez Caballero, Maria Galiana, Romero, Fabiola, Escurra, Clara, Rodriguez, Roque, Rolon, Roger, Valinotti, Elizabeth, Ayala, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554260/
http://dx.doi.org/10.1210/jendso/bvad114.1263
_version_ 1785116369796202496
author Rodriguez Caballero, Maria Galiana
Romero, Fabiola
Escurra, Clara
Rodriguez, Roque
Rolon, Roger
Valinotti, Elizabeth
Ayala, Alejandro
author_facet Rodriguez Caballero, Maria Galiana
Romero, Fabiola
Escurra, Clara
Rodriguez, Roque
Rolon, Roger
Valinotti, Elizabeth
Ayala, Alejandro
author_sort Rodriguez Caballero, Maria Galiana
collection PubMed
description Disclosure: M. Rodriguez Caballero: None. F. Romero: None. C. Escurra: None. R. Rodriguez: None. R. Rolon: None. E. Valinotti: None. A. Ayala: None. Granulomatous hypophysitis corresponds to 1% of sellar lesions. It maybe primary or secondary to tuberculosis, Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus or parasitic infections. Non-infectious etiologies include sarcoidosis, vasculitis, dendritic cell disorders, ruptured Rathke cysts or Crohn's disease. A 59-year-old immunocompetent woman was evaluated for decreased visual acuity, diplopia, and palsy of the 6(th) cranial nerve. Asellar MRI confirmed an 18 x 14 x 12 mm pituitary lesion with chiasmatic compression and visual field involvement. Hormonal evaluation revealed a TSH 0.03 mIU/L, FT4 0.44 ng/dL, random of GH 5.64 ng/mL, FSH 55.2 IU/mL, LH33.1 mIU/mL, and cortisol of 16 ng/dl. There was no evidence of diabetes insipidus. Transsphenoidal resection resulted in visual field improvement with a noticeable residual tumor of 12 x 9 x5 mm within the sellar space on the postoperative MRI. The patient developed panhypopituitarism. Pathology revealed non-caseous granulomatosis, with histiocytic aggregates of giant cells forming granulomas, with negative immunohistochemistry for mycobacteria. Tuberculin test, VDRL, blood cultures, ANA, Anti-DNA, ANCA C and P were negative. Tomography images and PET scan ruled out systemic involvement. The patient was treated with high doses of glucocorticoids under a presumptive diagnosis of isolated pituitary sarcoidosis vs. primary hypophysitis, resulting in complete disappearance of the lesion. Conclusion: Granulomatous hypophysitis is the second most common cause of chronic inflammation of the pituitary gland mimicking pituitary adenomas. Surgical removal and glucocorticoids are often utilized although there is no consensus regarding the treatment. Our case illustrates the importance of considering this diagnosis when confronted with incidental sellar lesions. Pharmacotherapy resulted in symptomatic improvement and complete involution of the pituitary lesion confirming the utility of empiric high-dose glucocorticoid as a therapeutic strategy for granulomatous hypophysitis. Presentation: Friday, June 16, 2023
format Online
Article
Text
id pubmed-10554260
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105542602023-10-06 FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids Rodriguez Caballero, Maria Galiana Romero, Fabiola Escurra, Clara Rodriguez, Roque Rolon, Roger Valinotti, Elizabeth Ayala, Alejandro J Endocr Soc Neuroendocrinology And Pituitary Disclosure: M. Rodriguez Caballero: None. F. Romero: None. C. Escurra: None. R. Rodriguez: None. R. Rolon: None. E. Valinotti: None. A. Ayala: None. Granulomatous hypophysitis corresponds to 1% of sellar lesions. It maybe primary or secondary to tuberculosis, Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus or parasitic infections. Non-infectious etiologies include sarcoidosis, vasculitis, dendritic cell disorders, ruptured Rathke cysts or Crohn's disease. A 59-year-old immunocompetent woman was evaluated for decreased visual acuity, diplopia, and palsy of the 6(th) cranial nerve. Asellar MRI confirmed an 18 x 14 x 12 mm pituitary lesion with chiasmatic compression and visual field involvement. Hormonal evaluation revealed a TSH 0.03 mIU/L, FT4 0.44 ng/dL, random of GH 5.64 ng/mL, FSH 55.2 IU/mL, LH33.1 mIU/mL, and cortisol of 16 ng/dl. There was no evidence of diabetes insipidus. Transsphenoidal resection resulted in visual field improvement with a noticeable residual tumor of 12 x 9 x5 mm within the sellar space on the postoperative MRI. The patient developed panhypopituitarism. Pathology revealed non-caseous granulomatosis, with histiocytic aggregates of giant cells forming granulomas, with negative immunohistochemistry for mycobacteria. Tuberculin test, VDRL, blood cultures, ANA, Anti-DNA, ANCA C and P were negative. Tomography images and PET scan ruled out systemic involvement. The patient was treated with high doses of glucocorticoids under a presumptive diagnosis of isolated pituitary sarcoidosis vs. primary hypophysitis, resulting in complete disappearance of the lesion. Conclusion: Granulomatous hypophysitis is the second most common cause of chronic inflammation of the pituitary gland mimicking pituitary adenomas. Surgical removal and glucocorticoids are often utilized although there is no consensus regarding the treatment. Our case illustrates the importance of considering this diagnosis when confronted with incidental sellar lesions. Pharmacotherapy resulted in symptomatic improvement and complete involution of the pituitary lesion confirming the utility of empiric high-dose glucocorticoid as a therapeutic strategy for granulomatous hypophysitis. Presentation: Friday, June 16, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10554260/ http://dx.doi.org/10.1210/jendso/bvad114.1263 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology And Pituitary
Rodriguez Caballero, Maria Galiana
Romero, Fabiola
Escurra, Clara
Rodriguez, Roque
Rolon, Roger
Valinotti, Elizabeth
Ayala, Alejandro
FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids
title FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids
title_full FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids
title_fullStr FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids
title_full_unstemmed FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids
title_short FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids
title_sort fri328 granulomatous hypophysitis with magnificent response to glucocorticoids
topic Neuroendocrinology And Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554260/
http://dx.doi.org/10.1210/jendso/bvad114.1263
work_keys_str_mv AT rodriguezcaballeromariagaliana fri328granulomatoushypophysitiswithmagnificentresponsetoglucocorticoids
AT romerofabiola fri328granulomatoushypophysitiswithmagnificentresponsetoglucocorticoids
AT escurraclara fri328granulomatoushypophysitiswithmagnificentresponsetoglucocorticoids
AT rodriguezroque fri328granulomatoushypophysitiswithmagnificentresponsetoglucocorticoids
AT rolonroger fri328granulomatoushypophysitiswithmagnificentresponsetoglucocorticoids
AT valinottielizabeth fri328granulomatoushypophysitiswithmagnificentresponsetoglucocorticoids
AT ayalaalejandro fri328granulomatoushypophysitiswithmagnificentresponsetoglucocorticoids